AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 150 participants.
Also called NCT03732794
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT03732794
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03732794. Allocation not applicable; no masking; primary purpose treatment. Start 2019-01-30 (actual); primary completion 2024-06-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
- Acronym
- ICE-AFIB
- Condition
- Atrial Fibrillation (AF)
- Condition
- Persistent Atrial Fibrillation
- Condition
- Longstanding Persistent Atrial Fibrillation
- Intervention (Device)
- AtriCure CryoICE & AtriClip LAA Exclusion
- Lead sponsor
- AtriCure, Inc.
Record details
- Record id
cardio:ct-nct03732794- Content hash
42b124a0074a7ba3a85cb8a0fabbd3573a288c0d0598e17a4250a06853997315